Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 3, 2011, Pages 309-316

  Sabri, Saher S ^a   Swee, Warren ^a   Turba, Ulku C ^a   Saad, Wael E A ^a   Park, Auh W ^a   Al Osaimi, Abdullah M ^a   Caldwell, Stephen H ^a   Matsumoto, Alan H ^a   Angle, John F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IODINATED POPPYSEED OIL; TETRADECYL SULFATE SODIUM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; CARDIOVASCULAR PROCEDURES; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; GAS; GASTRIC VARICES BLEEDING; HUMAN; IMAGE ANALYSIS; LIVER CIRRHOSIS; LUNG EMBOLISM; MALE; MEDICAL RECORD REVIEW; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; STOMACH HEMORRHAGE; STOMACH VARICES; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BALLOON OCCLUSION; EMBOLIZATION, THERAPEUTIC; ESOPHAGEAL AND GASTRIC VARICES; ETHIODIZED OIL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHLEBOGRAPHY; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; TIME FACTORS; TREATMENT OUTCOME; VEINS; VIRGINIA; YOUNG ADULT;

EID: 79952179768     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.11.022     Document Type: Article

References (37)

1. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11:51-58. (Pubitemid 26115062)
2. Chikamori F, Shibuya S, Takase Y, Ozaki A, Fukao K. Transjugular retrograde obliteration for gastric varices. Abdom Imaging 1996; 21:299-303. (Pubitemid 26230763)
3. Hiraga N, Aikata H, Takaki S, et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007; 42:663-72. Epub 2007 Aug 24. (Pubitemid 47278692)
4. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics. 2003; 23:911-920.
5. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23:921-37; discussion 937.
6. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001; 129:414-420. (Pubitemid 32289890)
7. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. Am J Roentgenol 2007; W365-W72.189:
8. Arai H, Abe T, Shimoda R, Takagi H, Yamada T, Mori M. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol 2005; 40:964-971. (Pubitemid 41662520)
9. Ninoi T, Nishida N, Kaminour T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: longterm follow-up in 78 patients. Am J Roentgenol 2005; 184:1340-1346. (Pubitemid 43821924)
10. Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. Am J Roentgenol 2002; 178:1167-1174. (Pubitemid 34411414)
11. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol 1998; 21:27-30. (Pubitemid 28048948)
12. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12:327-336. (Pubitemid 32217031)
13. Tessari L. Nouvelle technique d'obtention de la sclero-mousse, Phlebologie 2000; 53:339-342.
14. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16:1343-1349.
15. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25:307-12. (Pubitemid 27069047)
16. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126:1175-1189. (Pubitemid 38451188)
17. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171. (Pubitemid 24026884)
18. Rossle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001; 96:3379-3383. (Pubitemid 34016663)
19. Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51:270-274. (Pubitemid 34791460)
20. Zhuang ZW, Teng GJ, Jeffery RF, et al. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts. Am J Roentgenol 2002; 179:1597-1603. (Pubitemid 35386666)
21. Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386-400.
22. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000;46:1-15.
23. Abi-Jaoudeh N, Matsumoto AH, Angle JF, et al. TIPS rebleeding rates for different subtypes of varices in the era of covered stents. J Vasc Intervent Radiol 2008; 19 (Suppl 1):S77-S78.
24. Soehendra N, Nam VC, Grimm H, Kemperneers I. Endoscopic obliteration of large esophageal gastric varices with bucrylate. Endoscopy 1986; 18:25-26. (Pubitemid 16134957)
25. Hwang YH, Yeh HZ, Chen GH, et al. Endoscopic hemostasis of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: longterm efficacy and safety. Gastrointest Endosc 2000; 52:160-167.
26. Oho K, Iwao T, Sumino M, et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995; 27:349-354.
27. Lo GH, Liang HL, Chen WC, et al. A prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39:679-685.
28. Hong CH, Kim HJ, Park JH, et al. Treatment of patients with gastric variceal hemorrhage: Endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009; 24:372-378.
29. Demagny A. Comparative study into the efficacy of a sclerosant product in the form of liquid or foam in echo-guided of arches of the long and short saphenous veins. Phlebologie 2002; 55:133-137.
30. Smith C. Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology 2009; 24:260-269.
31. Gandini R, Chiocchi M, Konda D, et al. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. Cardiovasc Intervent Radiol 2008; 31:778-784.
32. Gandini R, Konda D, Reale CA, et al. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate - outcome in 244 patients. Radiology 2008; 246:612-618.
33. Tan KT, Kirby J, Rajan DK, Hayeems E, Beecroft JR. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol 2007; 18:343-351. (Pubitemid 46616717)
34. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008; 47:578-584. (Pubitemid 351258277)
35. Orsini C, Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg 2007; 33:1250-1254 (Pubitemid 47508677)
36. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008; 358:1525-1526. (Pubitemid 351482767)
37. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006; 43:162-164. (Pubitemid 43083525)